コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 bine, were used to treat epilepsy but caused urinary retention.
2 s infection, cancer, urinary obstruction, or urinary retention.
3 r development of secondary sequelae, such as urinary retention.
4 ORT: A 50-year-old male presented with acute urinary retention.
5 was associated with asymmetric weakness and urinary retention.
6 d lethality correlated with severe fecal and urinary retention.
7 dulla was responsible for the development of urinary retention.
8 showed signs of unbalanced hesitant walk and urinary retention.
9 lure, pneumonia, anastomotic leak, ileus, or urinary retention.
10 ess in the understanding of the causation of urinary retention.
11 Another patient had urinary retention.
12 d injury and also treat LUT symptoms such as urinary retention.
13 f concerns that they may predispose to acute urinary retention.
14 urinary flow rate, prostate volume, or acute urinary retention.
15 hyperplasia and the associated risk of acute urinary retention.
16 itis with quadriparesis, hyperaesthesia, and urinary retention.
17 rly effective in the treatment of women with urinary retention.
18 or painful distention of the bladder due to urinary retention.
19 g are effective in relieving obstruction and urinary retention.
20 a feeling of incomplete bladder emptying and urinary retention.
21 e, and reduces the risk of surgery and acute urinary retention.
22 resulted in a reduction in the rate of acute urinary retention (1.6% vs. 6.7%, a 77.3% relative reduc
24 er operation, the avulsed group demonstrated urinary retention, absence of bladder contractions and e
26 espiratory failure, urinary tract infection, urinary retention, anastomotic leak, and postoperative i
28 our understanding of the pathophysiology of urinary retention and incontinence where sensory feedbac
31 re post-MUS and pelvic organ prolapse repair urinary retention and obstruction, and urinary retention
32 has a role in the treatment of nonobstructed urinary retention and overactive bladder syndrome, espec
36 de alone reduced the long-term risk of acute urinary retention and the need for invasive therapy.
38 anglionic sudomotor dysfunction, 9 of 11 had urinary retention and xeropthalmia, and 6 of 8 had xeros
39 wo patients developed small abscesses, 1 had urinary retention, and 1 had minor bleeding during lipos
40 , one man was admitted to hospital for acute urinary retention, and another had stricture interventio
45 Such outcomes include hypotension, acute urinary retention, and the neuroleptic malignant syndrom
46 isease states, such as voiding postponement, urinary retention, and underactive or overactive bladder
48 ceration, paralytic ileus, pain, presyncope, urinary retention, and vomiting) and one patient had a g
49 nse criteria (aOR, 1.72; 95% CI, 1.21-2.46), urinary retention (aOR, 1.87; 95% CI, 1.18-2.96), fatigu
51 ical finding that both urge incontinence and urinary retention are responsive to this intervention.
52 taking anabolic steroids who presented with urinary retention, arthralgias, and peripheral edema, su
53 ely recruited 10 patients who presented with urinary retention as a neurological deficit that was att
56 obstruction runs the risk of inducing acute urinary retention, because of the inhibitory effect of a
57 current urinary tract infections, refractory urinary retention, bladder stones, or renal insufficienc
59 tients presented with prodromes of fever and urinary retention, but were misdiagnosed by physicians o
60 e mechanisms by which retigabine could cause urinary retention: by decreasing smooth muscle excitabil
61 age, anticholinergic medication, history of urinary retention, constipation, out-of-hours surgery, i
65 elop transient gastrointestinal dysmotility, urinary retention, dilated pupils, reduced heart rate va
66 A 10-year-old girl presented with ileus, urinary retention, dry mouth, lack of tears, fixed dilat
68 emergency department with a history of acute urinary retention, gross hematuria, and left flank pain
69 luded headache, myalgia, epididymo-orchitis, urinary retention, hematemesis, pneumonitis, and circula
71 outh in 8 of 79 (10%) vs 12 of 78 (15%), and urinary retention in 6 of 26 (23%) vs 3 of 18 (17%), res
75 rved: 1 intraabdominal abscess and 1 case of urinary retention in the TVA group; 1 early postoperativ
77 This article describes a specific cause of urinary retention in young women, associated with a fail
79 ulation, and clinical manifestations include urinary retention, incontinence, and recurrent urinary t
80 ces was assessed in 299 scenarios, including urinary retention, incontinence, wounds, urine volume me
81 ch as motor weakness, difficulty ambulating, urinary retention, increased nausea and vomiting, may de
83 ce of any adjudicated prostate cancer, acute urinary retention, invasive prostate surgical procedure,
84 the incidences of any prostate cancer, acute urinary retention, invasive surgical procedures, prostat
87 re not associated with a substantial risk of urinary retention nor with a substantial increase in res
90 aused by neuropathy or nerve damage, such as urinary retention or incontinence, as well as for the de
91 d flow rates, and reducing the risk of acute urinary retention or the requirement for benign prostati
92 Serious adverse events such as infection, urinary retention, or dyspareunia or other pain, excludi
93 ions, including spinal or epidural hematoma, urinary retention, or hemodynamic alterations, are advan
94 ficantly increased risk of repair breakdown, urinary retention, or residual incontinence up to 3 mont
97 e superior hypogastric plexus, postoperative urinary retention (POUR) may not be an uncommon problem.
98 Bar(Vglut2) ablation replicates the profound urinary retention produced by conventional lesions in th
99 a presumed protection against postoperative urinary retention (PUR), one of the most common complica
100 77%] of 564, OR 1.23 [95% CI 0.93 to 1.65]), urinary retention requiring catheterisation (LATP 35 [6%
102 ransient difficulty falling asleep, and mild urinary retention (requiring early morning voiding).
103 contrast, the implanted group showed reduced urinary retention, return of reflexive bladder voiding c
104 tension (RR, 1.91 [CI, 1.60 to 2.28]), acute urinary retention (RR, 1.98 [CI, 1.63 to 2.40]), and all
105 h bothersome lower urinary tract symptoms or urinary retention secondary to benign prostatic obstruct
106 in men with lower urinary tract symptoms or urinary retention secondary to benign prostatic obstruct
107 re conversion), postoperative complications (urinary retention, seroma), and need for overnight stay
108 rostatic hyperplasia, the incidence of acute urinary retention, the impact of therapy on the risk of
109 l haemorrhage (in six [2%] of 261 patients), urinary retention (three [1%]), and hypertension (three
110 1%] in the active surveillance group), acute urinary retention (three [2%] vs one [<1%]) and erectile
111 treated with HAL), two in the HAL group had urinary retention, two in the HAL group had vasovagal up
113 toms for all types of sling erosions include urinary retention, urge and mixed incontinence, but synt
114 Urological Association symptom score, acute urinary retention, urinary incontinence, renal insuffici
115 ology, dysfunctional voiding patterns, acute urinary retention, urine collection techniques, diagnosi
116 but are not limited to voiding dysfunction, urinary retention, vaginal extrusion and urinary tract e
122 ilateral PAE, lower baseline IPSS, and acute urinary retention were predictors of better clinical out
123 wo serious adverse events, polycythaemia and urinary retention, were considered related to siltuximab
124 t quality of life and may be associated with urinary retention, which can cause kidney insufficiency,